VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CCEL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CCELCryo-Cell International, Inc.
$4.89$39M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCCELQuarterly Financials

Cryo-Cell International, Inc. (CCEL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Cryo-Cell International, Inc. (CCEL) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CCEL Income Statement

Quarterly statement

CCEL Income Statement

Cryo-Cell International, Inc. (CCEL) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue7.82M7.78M7.68M7.84M7.83M7.93M7.97M8.02M8.07M8.04M7.85M7.88M7.87M7.77M7.82M7.76M7.68M7.63M7.26M7.32M
Revenue Growth %-0.02%-1.93%-3.59%-2.26%-2.99%-1.42%1.49%1.87%2.5%3.48%0.36%1.45%2.46%1.83%7.8%6.13%2.36%5.94%5.8%-2.99%
Cost of Goods Sold1.61M1.86M1.66M1.73M1.8M1.86M1.98M1.64M2.13M2.02M2.07M2.08M2.16M2.14M2.07M2.14M2.35M2.2M2.1M2.3M
COGS % of Revenue20.62%23.93%21.56%22.11%23.02%23.41%24.9%20.4%26.35%25.17%26.32%26.35%27.4%27.57%26.42%27.55%30.58%28.84%28.98%31.38%
Gross Profit6.21M5.92M6.03M6.11M6.02M6.07M5.98M6.39M5.94M6.02M5.79M5.8M5.71M5.63M5.76M5.63M5.33M5.43M5.16M5.02M
Gross Margin %79.38%76.07%78.44%77.89%76.98%76.59%75.1%79.6%73.65%74.83%73.68%73.65%72.6%72.43%73.58%72.45%69.42%71.16%71.02%68.62%
Gross Profit Growth %3.1%-2.59%0.71%-4.36%1.4%0.9%3.43%10.11%3.98%6.9%0.5%3.13%7.15%3.64%11.67%12.07%5.7%9.01%6.33%-3.97%
Operating Expenses4.02M4.72M5.26M10.08M4.12M4.58M4.93M6.51M4.55M4.63M4.96M21.98M4.55M4.6M4.07M5.04M3.96M4.24M3.68M5.83M
OpEx % of Revenue51.34%60.67%68.48%128.47%52.69%57.76%61.84%81.13%56.42%57.52%63.23%279.02%57.85%59.2%52.07%64.96%51.62%55.51%50.77%79.67%
Selling, General & Admin3.78M4.62M5.01M5.45M3.88M4.26M4.64M6.01M4.15M4.02M4.43M5.39M3.8M4.04M3.88M4.69M3.6M3.91M3.38M4.55M
SG&A % of Revenue48.3%59.39%65.23%69.47%49.53%53.7%58.2%74.9%51.44%50%56.4%68.47%48.34%51.96%49.57%60.39%46.91%51.26%46.51%62.19%
Research & Development53.62K99.78K65.76K84.78K61.63K131.71K98.14K304.63K193.93K241.09K502.89K443.81K344.13K304.68K78.83K76.4K80.27K80.9K147.22K30.44K
R&D % of Revenue0.69%1.28%0.86%1.08%0.79%1.66%1.23%3.8%2.4%3%6.4%5.63%4.37%3.92%1.01%0.98%1.05%1.06%2.03%0.42%
Other Operating Expenses184.48K0183.89K1000K185.69K190.1K191.85K194.94K207.26K367.8K33.19K1000K403.95K257.96K116.14K278.78K281.11K243.82K161.73K1000K
Operating Income2.19M1.2M765.13K-3.97M1.9M1.49M1.06M-122.35K1.39M1.39M821.22K-16.18M1.16M1.03M1.68M581.68K1.37M1.19M1.47M-808.43K
Operating Margin %28.04%15.4%9.96%-50.58%24.29%18.83%13.25%-1.52%17.23%17.3%10.46%-205.37%14.75%13.22%21.51%7.49%17.8%15.65%20.26%-11.05%
Operating Income Growth %15.43%-19.78%-27.54%-3142.24%36.74%7.27%28.59%99.24%19.71%35.38%-51.21%-2880.95%-15.09%-13.94%14.47%171.95%-14.34%-40.13%19.04%-137.08%
EBITDA2.53M1.54M1.11M-3.64M2.25M1.84M1.4M217.1K1.72M1.58M982.4K-15.77M1.58M1.46M2.13M1.03M1.81M1.64M1.94M-405.38K
EBITDA Margin %32.3%19.82%14.41%-46.37%28.81%23.17%17.52%2.71%21.35%19.65%12.51%-200.16%20.09%18.77%27.25%13.26%23.62%21.44%26.77%-5.54%
EBITDA Growth %12.11%-16.12%-20.69%-1775.05%30.88%16.26%42.1%101.38%8.94%8.28%-53.93%-1631.61%-12.86%-10.83%9.74%353.93%-8.93%-31.34%41.38%-117.37%
D&A (Non-Cash Add-back)333.44K343.53K342K330.23K353.63K344.26K340K339.45K332.47K188.5K161.18K409.91K419.99K431.23K449.27K447.71K446.99K441.92K472.72K403.05K
EBIT2.19M1.27M533.02K-4.15M1.72M1.13M1.03M-96.95K-1.82M1.8M1.05M-16.16M1.54M816.37K1.68M1.2M1.01M1.18M1.46M-822.23K
Net Interest Income-438.31K-441.92K-462.71K-481.95K-538.22K-551.13K-494.96K-745.49K-533.46K-329.27K-256.46K169.03K-469.64K-469.95K-466.23K-573.8K-365.35K-276.52K-306.1K-421.45K
Interest Income00000000000000000000
Interest Expense438.31K441.92K462.71K481.95K538.22K551.13K494.96K745.49K533.46K329.27K256.46K-169.03K469.64K469.95K466.23K573.8K365.35K276.52K306.1K421.45K
Other Income/Expense-368.28K-369.56K-694.83K-665.18K-714.54K-917.53K-522.29K-720.09K-10.03K80.66K-26.71K183.09K-93.42K-681.48K-468.64K40.83K-726.45K-294.59K-314.73K-435.24K
Pretax Income1.83M827.78K70.31K-4.63M1.19M575.1K533.72K-842.43K1.38M1.47M794.51K-15.99M1.07M346.42K1.21M622.51K640.97K899.78K1.16M-1.24M
Pretax Margin %23.33%10.65%0.92%-59.06%15.16%7.25%6.7%-10.5%17.11%18.3%10.12%-203.04%13.57%4.46%15.52%8.02%8.34%11.79%15.92%-17%
Income Tax554.96K273.19K23.2K58.64K-436.59K219.32K250.86K1.02M328.19K816.39K238.27K-4.8M387.06K125.44K447.71K-215.31K174.15K265.06K323.65K-606.49K
Effective Tax Rate %30.4%33%33%-1.27%-36.81%38.14%47%-120.98%23.78%55.45%29.99%30.03%36.25%36.21%36.86%-34.59%27.17%29.46%28%48.77%
Net Income1.27M554.59K47.11K-4.69M1.62M355.79K282.86K-1.86M1.05M655.79K556.24K-11.19M680.56K220.98K766.81K837.82K466.82K634.72K832.05K-637.19K
Net Margin %16.24%7.13%0.61%-59.8%20.73%4.49%3.55%-23.2%13.04%8.15%7.08%-142.06%8.65%2.84%9.8%10.79%6.08%8.32%11.46%-8.71%
Net Income Growth %-21.7%55.88%-83.35%-151.96%54.29%-45.75%-49.15%83.36%54.53%196.77%-27.46%-1435.61%45.79%-65.19%-7.84%231.49%-45.5%-45.78%19.96%-153.11%
Net Income (Continuing)1.27M554.59K47.11K-4.69M1.62M355.79K282.86K-1.86M1.05M655.79K556.24K-11.19M680.56K220.98K766.81K837.82K466.82K634.72K832.05K-637.19K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.160.070.01-0.460.090.040.03-0.230.130.080.07-1.340.080.030.090.100.060.070.10-0.07
EPS Growth %77.78%75%-80.67%-100%-30.77%-50%-55.49%82.84%62.5%166.67%-25.77%-1453.54%44.14%-59.57%-4.52%241.43%-44.5%-47%18.88%-143.75%
EPS (Basic)0.160.070.01-0.460.090.040.03-0.230.130.080.07-1.340.080.030.090.100.060.080.10-0.08
Diluted Shares Outstanding8.07M8.06M8.06M8.07M8.07M8.13M8.2M8.21M8.17M8.23M8.25M8.34M8.34M8.33M8.44M8.48M8.4M8.55M8.75M8.36M
Basic Shares Outstanding8.06M8.06M8.06M8.07M8.06M8.08M8.08M8.13M8.06M8.12M8.25M8.34M8.29M8.33M8.44M8.48M8.39M8.44M8.53M8.14M
Dividend Payout Ratio-----340.29%714.34%-------------